Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 USD | +0.93% | 0.00% | -30.32% |
09/05 | PMV Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
12/04 | Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.32% | 110M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- PMVP Stock
- News PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Names Michael Carulli as CFO; Phase 2 Trial of Tumor Treatment on Track